UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 000-02228

 

 

Medtronic, Inc.

(Exact name of registrant as specified in its charter)

 

 

710 Medtronic Parkway

Minneapolis, Minnesota 55432

(650) 645-3000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common stock, par value $0.10 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)		x
Rule 12g-4(a)(2)		¨
Rule 12h-3(b)(1)(i)		x
Rule 12h-3(b)(1)(ii)		¨
Rule 15d-6		¨

Approximate number of holders of record as of the certification or notice date: Common stock, par value $0.10 per share: 1

 

 

 

---

Pursuant to the requirements of the Securities Exchange Act of 1934, Medtronic, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

				MEDTRONIC, INC.
Date: February 27, 2015		By:		/s/ Gary L. Ellis
		Name:		Gary L. Ellis
		Title:		Executive Vice President and Chief Financial Officer